Financial Year |
March 31 2023 |
Monetary Funds |
10,868,918,125.10 |
Held-for-trading Financial Assets |
85,646,883.17 |
Notes Receivable |
1,696,035,558.06 |
Accounts Receivable |
2,567,800,461.63 |
Advances to Suppliers |
229,251,081.19 |
Other Receivables |
41,094,618.86 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,238,022,180.23 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
141,240,493.10 |
Total Current Assets |
17,868,009,401.34 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
1,069,401,024.18 |
Investment Properties |
-- |
Fixed Assetes |
3,917,351,793.42 |
Under-construction Projects |
648,717,550.98 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
598,209,661.01 |
R&D expenses |
125,253,323.41 |
Goodwill |
124,911,302.94 |
Long-Term Deferred and Prepaid Expenses |
159,247,563.97 |
Deferred Income Tax Assets |
266,282,143.75 |
Other Non-Current Assets |
179,954,620.35 |
Sub-Total of Non-Current Assets |
7,752,811,963.65 |
Total Assets |
25,620,821,364.99 |
Short-Term Loans |
1,800,000,000.00 |
Trading Financial liabilities |
4,110,695.40 |
Notes Payable |
1,025,619,252.39 |
Accounts Payable |
895,611,646.76 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
207,189,322.35 |
Taxes Payable |
253,542,557.70 |
Interest Payable |
-- |
Dividend Payable |
11,892,804.66 |
Other payables |
3,006,904,790.38 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
13,522,294.89 |
Other Current Liabilities |
87,157,470.84 |
Sub-Total of Current Liabilities |
7,357,540,795.56 |
Long-term Loans |
2,225,976,993.70 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
186,589,967.49 |
Other Non-Current Liabilities |
90,000,000.00 |
Sub-Total of Non-Current Liabilities |
2,847,126,490.90 |
Total Liabilities |
10,204,667,286.46 |
Paid-In Capital(Or Share Stock) |
935,552,687.00 |
Capital Surplus |
1,641,857,334.22 |
Surplus Reserve |
744,801,154.15 |
LESS:Treasury Stock |
177,799,240.43 |
Undistributed Profits |
11,019,545,415.81 |
Minority Stockholder's Interest |
1,131,252,049.40 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,284,902,029.13 |
Owner's Equity(Stockholder's Equity) |
15,416,154,078.53 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
25,620,821,364.99 |